Roivant Sciences Stock Investor Sentiment
ROIV Stock | USD 10.44 0.27 2.52% |
Slightly above 72% of Roivant Sciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Roivant Sciences suggests that many traders are alarmed. Roivant Sciences' investor sentiment overview provides quick insight into current market opportunities from investing in Roivant Sciences. The current market sentiment, together with Roivant Sciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Roivant Sciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Panic Vs Confidence
28
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Roivant Sciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Roivant Sciences.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Roivant Sciences stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Roivant daily returns and investor perception about the current price of Roivant Sciences as well as its diversification or hedging effects on your existing portfolios.
Roivant Historical Sentiment
Although Roivant Sciences' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Roivant, such as negative comments on social media and news outlets, may cause fear in the market and push Roivant Sciences' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Roivant.
Roivant |
Roivant Sciences Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Roivant Sciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Roivant Sciences Historical Investor Sentiment
Investor biases related to Roivant Sciences' public news can be used to forecast risks associated with an investment in Roivant. The trend in average sentiment can be used to explain how an investor holding Roivant can time the market purely based on public headlines and social activities around Roivant Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Roivant Sciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Roivant Sciences and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Roivant Sciences news discussions. The higher the estimate score, the more favorable the investor's outlook on Roivant Sciences.
Far too much social signal, news, headlines, and media speculation about Roivant Sciences that are available to investors today. That information is available publicly through Roivant media outlets and privately through word of mouth or via Roivant internal channels. However, regardless of the origin, that massive amount of Roivant data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Roivant Sciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Roivant Sciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Roivant Sciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Roivant Sciences alpha.
Roivant Sciences Performance against NYSE Composite
Price Growth (%) |
Timeline |
1 | Payment of 12377 shares by Venker Eric of Roivant Sciences subject to Rule 16b-3 | 01/23/2024 |
2 | 02/13/2024 |
3 | Payment of 16002 shares by Venker Eric of Roivant Sciences subject to Rule 16b-3 | 02/22/2024 |
4 | Disposition of 1630 shares by Richard Pulik of Roivant Sciences at 11.71 subject to Rule 16b-3 | 02/28/2024 |
5 | Disposition of 45361 shares by Qvt Financial Lp of Roivant Sciences subject to Rule 16b-3 | 03/07/2024 |
6 | Roivant Sciences Ltd. Receives Average Rating of Moderate Buy from Analysts - Defense World | 03/08/2024 |
7 | ROIV Stock Quote Price and Forecast - CNN | 03/12/2024 |
8 | Disposition of 10945 shares by Matthew Gline of Roivant Sciences at 10.01 subject to Rule 16b-3 | 03/20/2024 |
9 | Roivant Sciences Shares Gap Up to 10.08 - MarketBeat | 03/27/2024 |
10 | Disposition of 994373 shares by Matthew Gline of Roivant Sciences subject to Rule 16b-3 | 03/28/2024 |
11 | Roivant shares gain by positive brepocitinib trial results, Truist reiterates buy | 04/02/2024 |
12 | Roivant Sciences PT Raised to 15 at Deutsche Bank | 04/03/2024 |
13 | Disposition of 1856163 shares by Sukhatme Mayukh of Roivant Sciences subject to Rule 16b-3 | 04/05/2024 |
14 | Disposition of 3000000 shares by Vivek Ramaswamy of Roivant Sciences at 11.05 subject to Rule 16b-3 | 04/08/2024 |
Check out Roivant Sciences Hype Analysis, Roivant Sciences Correlation and Roivant Sciences Performance. For more information on how to buy Roivant Stock please use our How to Invest in Roivant Sciences guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Roivant Stock analysis
When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Is Roivant Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Roivant Sciences. If investors know Roivant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Roivant Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 5.27 | Revenue Per Share 0.16 | Quarterly Revenue Growth 1.178 | Return On Assets (0.14) | Return On Equity 1.058 |
The market value of Roivant Sciences is measured differently than its book value, which is the value of Roivant that is recorded on the company's balance sheet. Investors also form their own opinion of Roivant Sciences' value that differs from its market value or its book value, called intrinsic value, which is Roivant Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Roivant Sciences' market value can be influenced by many factors that don't directly affect Roivant Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Roivant Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Roivant Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Roivant Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.